🚀 VC round data is live in beta, check it out!
Healius Valuation Multiples
Discover revenue and EBITDA valuation multiples for Healius and similar public comparables like Atrys Health, Frontage Laboratories, Australian Clinical Labs, 908 Devices and more.
Healius Overview
About Healius
Healius is Australia’s second-largest pathology provider. Pathology revenue is almost entirely earned via the public health Medicare system and makes up the majority of Healius' group revenue. A small portion comes from its clinical testing business, Agilex.
Founded
1994
HQ
Employees
9.0K
Website
Financials (LTM)
EV
$884M
Healius Financials
Healius reported last 12-month revenue of $964M and EBITDA of $184M.
In the same LTM period, Healius generated $814M in gross profit, $184M in EBITDA, and had net loss of ($3M).
Revenue (LTM)
Healius P&L
In the most recent fiscal year, Healius reported revenue of $944M and EBITDA of $154M.
Healius expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $964M | XXX | $944M | XXX | XXX | XXX |
| Gross Profit | $814M | XXX | $793M | XXX | XXX | XXX |
| Gross Margin | 84% | XXX | 84% | XXX | XXX | XXX |
| EBITDA | $184M | XXX | $154M | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 16% | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | 1% | XXX | XXX | XXX |
| Net Profit | ($3M) | XXX | ($16M) | XXX | XXX | XXX |
| Net Margin | (0%) | XXX | (2%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Healius Stock Performance
Healius has current market cap of $260M, and enterprise value of $884M.
Market Cap Evolution
Healius' stock price is $0.36.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $884M | $260M | 1.4% | XXX | XXX | XXX | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHealius Valuation Multiples
Healius trades at 0.9x EV/Revenue multiple, and 4.8x EV/EBITDA.
EV / Revenue (LTM)
Healius Financial Valuation Multiples
As of April 14, 2026, Healius has market cap of $260M and EV of $884M.
Equity research analysts estimate Healius' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Healius has a P/E ratio of (88.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $260M | XXX | $260M | XXX | XXX | XXX |
| EV (current) | $884M | XXX | $884M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 4.8x | XXX | 5.7x | XXX | XXX | XXX |
| EV/EBIT | 34.4x | XXX | 80.4x | XXX | XXX | XXX |
| EV/Gross Profit | 1.1x | XXX | 1.1x | XXX | XXX | XXX |
| P/E | (88.3x) | XXX | (16.3x) | XXX | XXX | XXX |
| EV/FCF | 6.3x | XXX | 5.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Healius Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Healius Margins & Growth Rates
Healius' revenue in the last 12 month grew by 6%.
Healius' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Healius' rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Healius' rule of X is 32% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Healius Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 25% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 25% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | 51% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 84% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Healius Public Comps
See public comps and valuation multiples for other Laboratory Services and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Atrys Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Frontage Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| 908 Devices | XXX | XXX | XXX | XXX | XXX | XXX |
| Eurobio Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Healius M&A Activity
Healius acquired XXX companies to date.
Last acquisition by Healius was on XXXXXXXX, XXXXX. Healius acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Healius
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHealius Investment Activity
Healius invested in XXX companies to date.
Healius made its latest investment on XXXXXXXX, XXXXX. Healius invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Healius
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Healius
| When was Healius founded? | Healius was founded in 1994. |
| Where is Healius headquartered? | Healius is headquartered in Australia. |
| How many employees does Healius have? | As of today, Healius has over 9K employees. |
| Who is the CEO of Healius? | Healius' CEO is Paul R. Anderson. |
| Is Healius publicly listed? | Yes, Healius is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Healius? | Healius trades under HLS ticker. |
| When did Healius go public? | Healius went public in 1998. |
| Who are competitors of Healius? | Healius main competitors are Atrys Health, Frontage Laboratories, Australian Clinical Labs, 908 Devices. |
| What is the current market cap of Healius? | Healius' current market cap is $260M. |
| What is the current revenue of Healius? | Healius' last 12 months revenue is $964M. |
| What is the current revenue growth of Healius? | Healius revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Healius? | Current revenue multiple of Healius is 0.9x. |
| Is Healius profitable? | Yes, Healius is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Healius? | Healius' last 12 months EBITDA is $184M. |
| What is Healius' EBITDA margin? | Healius' last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of Healius? | Current EBITDA multiple of Healius is 4.8x. |
| What is the current FCF of Healius? | Healius' last 12 months FCF is $141M. |
| What is Healius' FCF margin? | Healius' last 12 months FCF margin is 15%. |
| What is the current EV/FCF multiple of Healius? | Current FCF multiple of Healius is 6.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.